Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies

Thrombotic microangiopathy (TMA) is most of the time caused by thrombotic thrombocytopenic purpura or hemolytic uremic syndrome. A 60-year-old female was diagnosed in 2014 with mammary breast adenocarcinoma treated by several-line therapy: mastectomy, docetaxel, cyclophosphamide, radiotherapy, doxor...

Descripción completa

Detalles Bibliográficos
Autores principales: Perrier, Quentin, Noble, Johan, Grangé, Steven, Bedouch, Pierrick, Tetaz, Rachel, Rostaing, Lionel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077600/
https://www.ncbi.nlm.nih.gov/pubmed/33976652
http://dx.doi.org/10.1159/000514982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077600/
https://www.ncbi.nlm.nih.gov/pubmed/33976652
http://dx.doi.org/10.1159/000514982

Ejemplares similares